Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
David Brennan
Pharma
How Alexion's asking AZ to up its offer almost cost it a deal
A surprising tax scrutiny almost derailed deal talks between Alexion and AstraZeneca ahead of their proposed $39 billion merger.
Angus Liu
Apr 14, 2021 11:38am
Alexion says top brass pressured staff to pad Soliris sales
Jan 5, 2017 9:26am
Emergency Alexion chief Brennan says he's '120% committed'
Dec 13, 2016 11:15am